US Broker Ratings

Zoetis Inc. (ZTS) Investor Outlook: Strong Buy Ratings and 14.25% Potential Upside

As an investor considering Zoetis Inc. (ZTS), the global leader in animal health solutions, there are several compelling reasons to keep this stock on your radar. With a current market..

ICON plc (ICLR) Stock Analysis: A 27.62% Potential Upside Amidst Healthcare Sector Volatility

ICON plc (NASDAQ: ICLR) stands out in the healthcare sector, particularly in the diagnostics and research industry, with an impressive market capitalization of $11.05 billion. Based in Dublin, Ireland, the..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring the 52% Upside Potential

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, is capturing investor attention with its potential for significant upside. Specializing in novel therapeutics for metabolic dysfunction-associated steatohepatitis..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: A Biotech Gem with 109% Potential Upside

Investors with an eye on the biotechnology sector might find Sarepta Therapeutics, Inc. (NASDAQ: SRPT) an intriguing opportunity, particularly given its substantial potential upside of 109.16% to an average target..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Exploring a 22% Potential Upside Amidst Healthcare Market Challenges

Bausch + Lomb Corporation (BLCO), a storied name in the healthcare sector, continues to navigate the complexities of the medical instruments and supplies industry. With roots tracing back to 1853,..

Labcorp Holdings Inc. (LH) Stock Analysis: Navigating a 7.85% Potential Upside Amidst a Strong Buy Consensus

Labcorp Holdings Inc. (NYSE: LH) stands as a significant player in the healthcare sector, specifically within the Diagnostics & Research industry. With a robust market capitalization of $21.26 billion, Labcorp..

Charles River Laboratories (CRL) Stock Analysis: Evaluating Growth Potential Amidst Diagnostic Sector Challenges

Charles River Laboratories International, Inc. (NYSE: CRL) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Founded in 1947 and headquartered in Wilmington, Massachusetts,..

Haleon plc (HLN) Stock Analysis: Exploring Its 4.54% Potential Upside and Strategic Market Position

Haleon plc (HLN), a prominent player in the healthcare sector, has been making waves in the drug manufacturing industry with its impressive array of consumer healthcare products. As a UK-based..

Blueprint Medicines Corporation (BPMC) Stock Analysis: Navigating Biotech Growth with 55.5% Revenue Surge

Blueprint Medicines Corporation (NASDAQ: BPMC) stands out in the biotechnology sector, not just for its innovative approach to precision therapy, but also for its impressive 55.5% revenue growth, which sets..

Guardant Health, Inc. (GH) Stock Analysis: Navigating a 23.67% Potential Upside in the Dynamic Diagnostics Sector

Guardant Health, Inc. (NASDAQ: GH) stands out as a pivotal player in the rapidly evolving field of precision oncology. With a market capitalization of $5.95 billion, the company is at..

BrightSpring Health Services (BTSG) Stock Analysis: Strong Buy Ratings and a 12.55% Upside Potential

BrightSpring Health Services, Inc. (NYSE: BTSG), a key player in the Health Information Services industry, has been catching the eye of investors with its robust buy ratings and promising future..

Walgreens Boots Alliance (WBA) Stock Analysis: A Deep Dive into Healthcare Retail’s 8.89% Dividend Yield

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is a prominent player in the healthcare sector, specifically in pharmaceutical retailing. With its expansive presence across the United States and international markets, Walgreens..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 20.51% Upside with Strong Buy Ratings

For investors with an eye on the healthcare sector, Alcon Inc. (NYSE: ALC) presents a compelling opportunity. As a leading player in the medical instruments and supplies industry, Alcon focuses..

Qiagen N.V. (QGEN) Stock Analysis: Exploring an 8.52% Potential Upside in the Healthcare Sector

Qiagen N.V. (NYSE: QGEN) stands as a prominent player in the diagnostics and research industry, offering a comprehensive suite of solutions that bridge biological samples to actionable molecular insights. Headquartered..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Strong Buy Ratings and 27% Potential Upside

Neurocrine Biosciences, Inc. (NBIX) stands out in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $12.41 billion, this San Diego-based company..

HCA Healthcare, Inc. (HCA) Stock Analysis: Navigating a Robust Market Cap with Impressive ROE

HCA Healthcare, Inc. (NYSE: HCA) stands out in the healthcare sector not only for its substantial market capitalization of $92.46 billion but also for its impressive operational metrics that could..

Teleflex Incorporated (TFX) Stock Analysis: Potential 26.97% Upside in the Healthcare Sector

Teleflex Incorporated (NYSE: TFX) stands as a notable player in the healthcare sector, specializing in the design and supply of single-use medical devices. With a market capitalization of $5.43 billion,..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring an 8.5% Upside in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector should consider Henry Schein, Inc. (NASDAQ: HSIC), a key player in medical distribution with a market capitalization of $8.8 billion. Based in Melville,..

ADMA Biologics Inc (ADMA) Stock Analysis: Potential 43% Upside Amid Robust Revenue Growth

ADMA Biologics Inc (NASDAQ: ADMA) is capturing the attention of investors with its promising growth trajectory in the biotechnology sector. As a key player in the healthcare industry, ADMA specializes..

Option Care Health, Inc. (OPCH) Stock Analysis: A 20.86% Upside Awaits with Strong Buy Ratings

Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is capturing investor attention with its robust growth prospects and..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds